These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11117982)

  • 21. Bad news for dieters: a focus on ephedrine.
    Riffel K
    Kans Nurse; 2003 Apr; 78(4):6-9. PubMed ID: 12769034
    [No Abstract]   [Full Text] [Related]  

  • 22. Phenylpropanolamine-associated intracranial hemorrhage in an infant.
    Hamilton RS; Sharieff G
    Am J Emerg Med; 2000 May; 18(3):343-5. PubMed ID: 10830700
    [No Abstract]   [Full Text] [Related]  

  • 23. Psychiatric complications of Ma-huang.
    Jacobs KM; Hirsch KA
    Psychosomatics; 2000; 41(1):58-62. PubMed ID: 10665269
    [No Abstract]   [Full Text] [Related]  

  • 24. Stroke and phenylpropanolamine (continued).
    Prescrire Int; 2001 Aug; 10(54):120. PubMed ID: 11718184
    [No Abstract]   [Full Text] [Related]  

  • 25. Don't be so quick to ban medications.
    De FL
    CMAJ; 2002 Jan; 166(1):13. PubMed ID: 11800236
    [No Abstract]   [Full Text] [Related]  

  • 26. FDA proposes constraints on ephedrine dietary supplements.
    Am J Health Syst Pharm; 1997 Jul; 54(14):1578. PubMed ID: 9248599
    [No Abstract]   [Full Text] [Related]  

  • 27. Combining nonprescription medications.
    Shuster J
    Nursing; 1998 Jun; 28(6):77. PubMed ID: 9668801
    [No Abstract]   [Full Text] [Related]  

  • 28. Hypertensive responses induced by phenylpropanolamine in anorectic and decongestant preparations.
    Horowitz JD; Lang WJ; Howes LG; Fennessy MR; Christophidis N; Rand MJ; Louis WJ
    Lancet; 1980 Jan; 1(8159):60-1. PubMed ID: 6153233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurological and cardiac events on phenylpropanolamine.
    Prescrire Int; 1999 Dec; 8(44):181. PubMed ID: 11503819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute hepatitis associated with the use of a Chinese herbal product, ma-huang.
    Nadir A; Agrawal S; King PD; Marshall JB
    Am J Gastroenterol; 1996 Jul; 91(7):1436-8. PubMed ID: 8678010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The federal ban on ephedrine dietary supplements:an important event for pain practitioners and patients.
    Lipman AG
    J Pain Palliat Care Pharmacother; 2004; 18(3):1-4. PubMed ID: 15364627
    [No Abstract]   [Full Text] [Related]  

  • 32. [Ephedrine and ephedra in weight loss products and other preparations].
    van der Hooft CS; Stricker BH
    Ned Tijdschr Geneeskd; 2002 Jul; 146(28):1335-6. PubMed ID: 12148223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Balancing safety of dietary supplements with the free market.
    Lewis JD; Strom BL
    Ann Intern Med; 2002 Apr; 136(8):616-8. PubMed ID: 11955030
    [No Abstract]   [Full Text] [Related]  

  • 34. Firm signs consent decree prohibiting ephedrine products.
    FDA Consum; 2002; 36(4):5. PubMed ID: 12184309
    [No Abstract]   [Full Text] [Related]  

  • 35. Ephedra-containing dietary supplements in the US versus ephedra as a Chinese medicine.
    Mehendale SR; Bauer BA; Yuan CS
    Am J Chin Med; 2004; 32(1):1-10. PubMed ID: 15154280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FDA v. ephedra: is it time to lift the ban?
    Pyle KR
    Food Drug Law J; 2006; 61(4):701-51. PubMed ID: 17180770
    [No Abstract]   [Full Text] [Related]  

  • 37. Ma-huang strikes again: ephedrine nephrolithiasis.
    Powell T; Hsu FF; Turk J; Hruska K
    Am J Kidney Dis; 1998 Jul; 32(1):153-9. PubMed ID: 9669437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenylpropanolamine and the risk of hemorrhagic stroke.
    Kernan WN; Viscoli CM; Brass LM; Broderick JP; Brott T; Feldmann E; Morgenstern LB; Wilterdink JL; Horwitz RI
    N Engl J Med; 2000 Dec; 343(25):1826-32. PubMed ID: 11117973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severe hepatotoxicity associated with the use of weight loss diet supplements containing ma huang or usnic acid.
    Neff GW; Reddy KR; Durazo FA; Meyer D; Marrero R; Kaplowitz N
    J Hepatol; 2004 Dec; 41(6):1062-4. PubMed ID: 15582145
    [No Abstract]   [Full Text] [Related]  

  • 40. Psychiatric effects of ephedra: addiction.
    Miller SC
    Am J Psychiatry; 2005 Nov; 162(11):2198. PubMed ID: 16263877
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.